EXAS

Exact Sciences Corp. is a molecular diagnostics company specializing in the detection and prevention of cancer. The company is best known for Cologuard, a non-invasive stool DNA screening test for colorectal cancer that has become a widely adopted alternative to colonoscopy for average-risk patients. Exact Sciences has expanded its portfolio through acquisitions and internal development to include blood-based cancer tests and precision oncology solutions. The company also offers genomic profiling services to help oncologists select targeted therapies for cancer patients. Exact Sciences operates laboratories and commercializes its tests through partnerships with healthcare providers and payers.